Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 31% ± 15% | |
brain | 8 studies | 27% ± 9% | |
intestine | 8 studies | 23% ± 8% | |
peripheral blood | 7 studies | 21% ± 5% | |
kidney | 7 studies | 25% ± 7% | |
uterus | 4 studies | 35% ± 17% | |
breast | 4 studies | 21% ± 3% | |
placenta | 3 studies | 40% ± 9% | |
eye | 3 studies | 24% ± 4% | |
bone marrow | 3 studies | 19% ± 5% | |
liver | 3 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 15346.78 | 459 / 459 | 100% | 374.56 | 1118 / 1118 |
esophagus | 100% | 13022.82 | 1445 / 1445 | 100% | 179.47 | 183 / 183 |
prostate | 100% | 14249.57 | 245 / 245 | 100% | 281.15 | 502 / 502 |
skin | 100% | 13251.77 | 1809 / 1809 | 100% | 623.60 | 472 / 472 |
lung | 100% | 20653.71 | 578 / 578 | 100% | 307.30 | 1154 / 1155 |
uterus | 100% | 16287.38 | 170 / 170 | 100% | 265.38 | 458 / 459 |
ovary | 100% | 13406.31 | 180 / 180 | 100% | 289.18 | 429 / 430 |
thymus | 100% | 15559.87 | 653 / 653 | 100% | 368.45 | 603 / 605 |
kidney | 100% | 16031.15 | 89 / 89 | 100% | 514.05 | 898 / 901 |
stomach | 100% | 15439.36 | 359 / 359 | 100% | 229.56 | 285 / 286 |
intestine | 100% | 15892.23 | 966 / 966 | 99% | 260.43 | 524 / 527 |
brain | 99% | 7843.15 | 2623 / 2642 | 100% | 500.85 | 704 / 705 |
bladder | 100% | 16096.19 | 21 / 21 | 99% | 273.02 | 499 / 504 |
adrenal gland | 100% | 16245.85 | 258 / 258 | 98% | 210.23 | 226 / 230 |
pancreas | 99% | 5824.55 | 324 / 328 | 99% | 427.20 | 176 / 178 |
liver | 100% | 8339.60 | 226 / 226 | 96% | 162.51 | 390 / 406 |
adipose | 100% | 15813.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 25572.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 667.62 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 129.35 | 29 / 29 |
spleen | 100% | 12006.03 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 190.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 110.38 | 1 / 1 |
heart | 100% | 12625.41 | 857 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 7971.71 | 876 / 929 | 0% | 0 | 0 / 0 |
muscle | 93% | 5153.86 | 748 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0043518 | Biological process | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0006606 | Biological process | protein import into nucleus |
GO_1902254 | Biological process | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
GO_0002039 | Molecular function | p53 binding |
Gene name | PTTG1IP |
Protein name | Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor) PTTG1 interacting protein PTTG1 interacting protein (cDNA FLJ58034, moderately similar to Pituitary tumor-transforming gene 1protein-interacting protein) |
Synonyms | C21orf3 C21orf1 |
Description | FUNCTION: May facilitate PTTG1 nuclear translocation. |
Accessions | ENST00000330938.8 ENST00000397887.7 A8MZH8 B4DPZ0 A8MXQ1 ENST00000445724.3 ENST00000397886.3 P53801 |